Clinical trials start with Phase I to assess drug safety in a small group. Phase II tests effectiveness and side effects on a larger group. Phase III compares the new drug to existing treatments ...

With updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug ...

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

The deal will see BMS partner with BioNTech on a bispecific antibody candidate, dubbed BNT327, of which the latter company is ...

Prothena has already discontinued the development of birtamimab, and anticipates further spending cuts, including workforce ...

The new approach would help improve drug safety, lower research and development costs and drug ... which are expected to be rolled out in phases.

The investment comes as the FDA is pushing drug developers to phase out animal testing in some of the biologic treatments ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...

Deepak Bhamidipati, MD, discusses a review conducted to investigate how the design of early-phase clinical trials has evolved ...